<DOC>
	<DOC>NCT01538498</DOC>
	<brief_summary>- Primary objectives: To develop peritoneal carcinomatosis index (PCI) for ovarian cancer, tubal cancer and primary peritoneal cancer that can represent perioperative intraperitoneal tumor burden objectively - Secondary objectives: To establish the relationship and find out clinical significance between PCI, tumor location and tumor characteristics</brief_summary>
	<brief_title>Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer</brief_title>
	<detailed_description>Patients with primary ovarian cancer - Informed consent - Digital photography &amp; Checking PCI (tumor size, number, and Characteristics) - Postoperative surveillance(tumor marker, image and physical examination) 1. Developing the best fitting PCI model to reflect recurrence-free survival and overall survival - Selection of items - Weighting by items and tumor characteristics 2. Analysis of prognostic impact of PCI compared to conventional staging system (FIGO stage) for ovarian cancer</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<criteria>1. Preoperative clinical diagnosis of ovarian cancer, tubal cancer, and primary peritoneal carcinoma (all stage) 2. Available preoperative image study (CT and/or MRI and/or PET) 3. Patients who gave a written informed consent 4. Patients must be surgical candidate considering medical and psychological condition Patients who refuse to participate or want to withdraw at anytime.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>PCI</keyword>
	<keyword>Ovarian cancer</keyword>
</DOC>